Literature DB >> 23475750

Fatal and unanticipated cardiorespiratory disease in a two-year-old child with hurler syndrome following successful stem cell transplant.

Sampada Gupta1, Anne O'Meara, Robert Wynn, Michael McDermott.   

Abstract

A 2-year-old female with Hurler syndrome (mucopolysaccharidosis type 1) died suddenly within 3 months of successful unrelated fully matched cord blood transplant, having received weekly enzyme replacement therapy (ERT) prior to transplant. Though an infectious aetiology was clinically suspected to be the cause of her unanticipated acute deterioration and untimely demise, autopsy findings suggested that a combination of pre-existing but sub-clinical Hurler related cardiopulmonary pathology and superimposed transplant related pulmonary venopathy as the basis of her death. This case highlights the limitations of ERT in ameliorating cardiorespiratory disease and the failure of standard pre-transplant investigations to detect significant abnormality related to her underlying condition. It also reinforces the importance of autopsy in explaining unanticipated events.

Entities:  

Year:  2013        PMID: 23475750      PMCID: PMC3755573          DOI: 10.1007/8904_2013_213

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  23 in total

Review 1.  Newborn screening of lysosomal storage disorders.

Authors:  Deborah Marsden; Harvey Levy
Journal:  Clin Chem       Date:  2010-05-20       Impact factor: 8.327

Review 2.  The clinical outcome of Hurler syndrome after stem cell transplantation.

Authors:  Mieke Aldenhoven; Jaap Jan Boelens; Tom J de Koning
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

3.  Pre-transplant risk factors affecting outcome in Hurler syndrome.

Authors:  P J Orchard; C Milla; E Braunlin; T DeFor; K Bjoraker; B R Blazar; C Peters; J Wagner; J Tolar
Journal:  Bone Marrow Transplant       Date:  2009-11-09       Impact factor: 5.483

4.  Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Authors:  Selim Corbacioglu; Simone Cesaro; Maura Faraci; Dominique Valteau-Couanet; Bernd Gruhn; Attilio Rovelli; Jaap J Boelens; Annette Hewitt; Johanna Schrum; Ansgar S Schulz; Ingo Müller; Jerry Stein; Robert Wynn; Johann Greil; Karl-Walter Sykora; Susanne Matthes-Martin; Monika Führer; Anne O'Meara; Jacek Toporski; Petr Sedlacek; Paul G Schlegel; Karoline Ehlert; Anders Fasth; Jacek Winiarski; Johan Arvidson; Christine Mauz-Körholz; Hulya Ozsahin; Andre Schrauder; Peter Bader; Joseph Massaro; Ralph D'Agostino; Margaret Hoyle; Massimo Iacobelli; Klaus-Michael Debatin; Christina Peters; Giorgio Dini
Journal:  Lancet       Date:  2012-02-23       Impact factor: 79.321

5.  Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.

Authors:  Daniel H Wiseman; Jean Mercer; Karen Tylee; Nilima Malaiya; Denise K Bonney; Simon A Jones; J Edmond Wraith; Robert F Wynn
Journal:  J Inherit Metab Dis       Date:  2012-06-21       Impact factor: 4.982

6.  Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.

Authors:  J Cox-Brinkman; J-J Boelens; J E Wraith; A O'meara; P Veys; F A Wijburg; N Wulffraat; R F Wynn
Journal:  Bone Marrow Transplant       Date:  2006-05-22       Impact factor: 5.483

7.  Echocardiographic study of paediatric patients with mucopolysaccharidosis.

Authors:  Gabriela N Leal; Ana C de Paula; Cláudio Leone; Chong A Kim
Journal:  Cardiol Young       Date:  2010-04-26       Impact factor: 1.093

Review 8.  Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature.

Authors:  A Gassas; L Sung; J J Doyle; J T R Clarke; E Fred Saunders
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

9.  Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients.

Authors:  C C Barker; J D Butzner; R A Anderson; R Brant; R S Sauve
Journal:  Bone Marrow Transplant       Date:  2003-07       Impact factor: 5.483

10.  Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure.

Authors:  J J Boelens; R F Wynn; A O'Meara; P Veys; Y Bertrand; G Souillet; J E Wraith; A Fischer; M Cavazzana-Calvo; K W Sykora; P Sedlacek; A Rovelli; C S P M Uiterwaal; N Wulffraat
Journal:  Bone Marrow Transplant       Date:  2007-05-28       Impact factor: 5.483

View more
  1 in total

1.  The Carotid Intima-Media Thickness and Arterial Stiffness of Pediatric Mucopolysaccharidosis Patients Are Increased Compared to Both Pediatric and Adult Controls.

Authors:  Raymond Y Wang; Kyle D Rudser; Donald R Dengel; Elizabeth A Braunlin; Julia Steinberger; David R Jacobs; Alan R Sinaiko; Aaron S Kelly
Journal:  Int J Mol Sci       Date:  2017-03-15       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.